Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 3Lymphoid 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1CNS 1

Conditions

Myelodysplastic Syndromes 211Leukemia, Myeloid, Acute 181Precursor Cell Lymphoblastic Leukemia-Lymphoma 162Leukemia 125Lymphoma, Non-Hodgkin 112Hodgkin Disease 102Leukemia, Lymphocytic, Chronic, B-Cell 99Multiple Myeloma 97Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91Lymphoma 88Myeloproliferative Disorders 87Lymphoma, Follicular 72Leukemia, Myelomonocytic, Chronic 72Leukemia, Myeloid, Chronic-Phase 71Lymphoma, Mantle-Cell 70Burkitt Lymphoma 67Leukemia, Myeloid, Accelerated Phase 65Primary Myelofibrosis 62Lymphoma, B-Cell, Marginal Zone 61Lymphoma, Large B-Cell, Diffuse 60Blast Crisis 53Anemia, Refractory, with Excess of Blasts 51Lymphoma, Large-Cell, Immunoblastic 50Congenital Abnormalities 50Neoplasms, Plasma Cell 47Myelodysplastic-Myeloproliferative Diseases 45Dendritic Cell Sarcoma, Interdigitating 41Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 38Graft vs Host Disease 38Leukemia, Biphenotypic, Acute 37

Interventions

eltrombopag 3Platelet Transfusion 2Busulfan 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2siltuximab 1oprelvekin 1fludarabine phosphate 1fludarabine 1Vitamin E 1Tranexamic Acid 1Topotecan 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1Observation 1Microarray Analysis 1Isotretinoin 1Interleukin-11 1Hematopoietic Stem Cell Transplantation 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Etoposide 1Decitabine 1DNA Methylation 1Cytogenetic Analysis 1Cytarabine 1Cyclophosphamide 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × Cyclophosphamide × Myeloid × Clear all
NCT03303950 2022-05-05

Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

University of Utah

Phase 2 Terminated
6 enrolled 17 charts
Classical hematologyMyeloidPlasma cell

Anemia, Multiple Myeloma, Thrombocytopenia, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡